Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation

Abstract Purpose The aim of this study was to evaluate the added diagnostic value of additional second stage pelvic scanning as part of the [18F]DCFPYL PET/CT procedure in patients treated for prostate cancer (PCa) who have biochemical recurrence (BR). Materials and methods Consecutive patients with...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Rodríguez-Pajuelo, Miriam Guerra-Gómez, Juan Ignacio Cuenca Cuenca, José María Freire-Macías, José Manuel Jiménez-Hoyuela García, Rosa María Álvarez-Pérez
Format: Article
Language:English
Published: Springer 2025-02-01
Series:EJNMMI Reports
Subjects:
Online Access:https://doi.org/10.1186/s41824-025-00238-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572073918070784
author Ana Rodríguez-Pajuelo
Miriam Guerra-Gómez
Juan Ignacio Cuenca Cuenca
José María Freire-Macías
José Manuel Jiménez-Hoyuela García
Rosa María Álvarez-Pérez
author_facet Ana Rodríguez-Pajuelo
Miriam Guerra-Gómez
Juan Ignacio Cuenca Cuenca
José María Freire-Macías
José Manuel Jiménez-Hoyuela García
Rosa María Álvarez-Pérez
author_sort Ana Rodríguez-Pajuelo
collection DOAJ
description Abstract Purpose The aim of this study was to evaluate the added diagnostic value of additional second stage pelvic scanning as part of the [18F]DCFPYL PET/CT procedure in patients treated for prostate cancer (PCa) who have biochemical recurrence (BR). Materials and methods Consecutive patients with a diagnosis of PCa who underwent a dual-phase PSMA-PET scan between September 2022 and December 2023, were retrospectively included. We analyzed the number and maximum SUV (SUVmax) of lesions only in the pelvic region (prostate, locoregional lymph nodes and bone), based on PSMA-RADS version 2.0 and miTNM criteria. To assess the potential diagnostic benefit of additional delayed pelvic PET/CT imaging as part of the PSMA-PET procedure, the change in molecular TNM classification was evaluated after the procedure. Results Additional delayed pelvic PET/CT imaging as part of the PSMA-PET procedure resulted in a change in molecular TNM classification in 22 out of 136 patients (16.2%). The highest percentage change was obtained in the miN classification (14/22 patients), followed by the miT classification (7/22) and lastly miM (1/22). Moreover, we found that patients in whom delayed pelvic imaging resulted in a change in molecular TNM classification were significantly older and had a higher PSA level than those in whom delayed imaging did not provide additional information. Conclusions Pelvic delayed imaging in patients with biochemical recurrence of prostate cancer undergoing PET/CT with [18F]DCFPYL shows a non-negligible influence on patient staging, modifying the miTNM classification in 16.2% of cases, with pelvic lymphatic involvement benefiting the most from the dual study.
format Article
id doaj-art-6bd20ca31aa748c0a99998432f630e1b
institution Kabale University
issn 3005-074X
language English
publishDate 2025-02-01
publisher Springer
record_format Article
series EJNMMI Reports
spelling doaj-art-6bd20ca31aa748c0a99998432f630e1b2025-02-02T12:05:40ZengSpringerEJNMMI Reports3005-074X2025-02-019111110.1186/s41824-025-00238-8Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluationAna Rodríguez-Pajuelo0Miriam Guerra-Gómez1Juan Ignacio Cuenca Cuenca2José María Freire-Macías3José Manuel Jiménez-Hoyuela García4Rosa María Álvarez-Pérez5Nuclear Medicine Department, University Hospital Virgen del RocíoNuclear Medicine Department, University Hospital Virgen del RocíoNuclear Medicine Department, University Hospital Virgen del RocíoNuclear Medicine Department, University Hospital Virgen del RocíoNuclear Medicine Department, University Hospital Virgen del RocíoNuclear Medicine Department, University Hospital Virgen del RocíoAbstract Purpose The aim of this study was to evaluate the added diagnostic value of additional second stage pelvic scanning as part of the [18F]DCFPYL PET/CT procedure in patients treated for prostate cancer (PCa) who have biochemical recurrence (BR). Materials and methods Consecutive patients with a diagnosis of PCa who underwent a dual-phase PSMA-PET scan between September 2022 and December 2023, were retrospectively included. We analyzed the number and maximum SUV (SUVmax) of lesions only in the pelvic region (prostate, locoregional lymph nodes and bone), based on PSMA-RADS version 2.0 and miTNM criteria. To assess the potential diagnostic benefit of additional delayed pelvic PET/CT imaging as part of the PSMA-PET procedure, the change in molecular TNM classification was evaluated after the procedure. Results Additional delayed pelvic PET/CT imaging as part of the PSMA-PET procedure resulted in a change in molecular TNM classification in 22 out of 136 patients (16.2%). The highest percentage change was obtained in the miN classification (14/22 patients), followed by the miT classification (7/22) and lastly miM (1/22). Moreover, we found that patients in whom delayed pelvic imaging resulted in a change in molecular TNM classification were significantly older and had a higher PSA level than those in whom delayed imaging did not provide additional information. Conclusions Pelvic delayed imaging in patients with biochemical recurrence of prostate cancer undergoing PET/CT with [18F]DCFPYL shows a non-negligible influence on patient staging, modifying the miTNM classification in 16.2% of cases, with pelvic lymphatic involvement benefiting the most from the dual study.https://doi.org/10.1186/s41824-025-00238-8Prostate cancerDual-phasePSMA-PET[18F]DCFPYLPSMA-RADS.
spellingShingle Ana Rodríguez-Pajuelo
Miriam Guerra-Gómez
Juan Ignacio Cuenca Cuenca
José María Freire-Macías
José Manuel Jiménez-Hoyuela García
Rosa María Álvarez-Pérez
Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
EJNMMI Reports
Prostate cancer
Dual-phase
PSMA-PET
[18F]DCFPYL
PSMA-RADS.
title Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
title_full Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
title_fullStr Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
title_full_unstemmed Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
title_short Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
title_sort impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using 18f dcfpyl pet ct a retrospective evaluation
topic Prostate cancer
Dual-phase
PSMA-PET
[18F]DCFPYL
PSMA-RADS.
url https://doi.org/10.1186/s41824-025-00238-8
work_keys_str_mv AT anarodriguezpajuelo impactofdelayedpelvicimagingonthestagingofbiochemicalrecurrenceinprostatecancerpatientsusing18fdcfpylpetctaretrospectiveevaluation
AT miriamguerragomez impactofdelayedpelvicimagingonthestagingofbiochemicalrecurrenceinprostatecancerpatientsusing18fdcfpylpetctaretrospectiveevaluation
AT juanignaciocuencacuenca impactofdelayedpelvicimagingonthestagingofbiochemicalrecurrenceinprostatecancerpatientsusing18fdcfpylpetctaretrospectiveevaluation
AT josemariafreiremacias impactofdelayedpelvicimagingonthestagingofbiochemicalrecurrenceinprostatecancerpatientsusing18fdcfpylpetctaretrospectiveevaluation
AT josemanueljimenezhoyuelagarcia impactofdelayedpelvicimagingonthestagingofbiochemicalrecurrenceinprostatecancerpatientsusing18fdcfpylpetctaretrospectiveevaluation
AT rosamariaalvarezperez impactofdelayedpelvicimagingonthestagingofbiochemicalrecurrenceinprostatecancerpatientsusing18fdcfpylpetctaretrospectiveevaluation